* Bruker Corp BRKR.OQ reported quarterly adjusted earnings
of 76
cents per share for the quarter ended December 31, lower than
the same quarter last year, when the company reported EPS of 80
cents. The mean expectation of fourteen analysts for the
quarter was for earnings of 74 cents per share. Wall Street
expected results to range from 71 cents to 76 cents per share.
* Revenue rose 14.6% to $979.60 million from a year ago;
analysts
expected $966.35 million.
* Bruker Corp's reported EPS for the quarter was 9 cents.
* The company reported quarterly net income of $13.7
million.
* Bruker Corp shares had fallen by 11.9% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Bruker Corp is
$72.21
This summary was machine generated from LSEG data February 13 at
03:19 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 0.74 0.76 Beat
Sep. 30 2024 0.59 0.60 Beat
Jun. 30 2024 0.52 0.52 Met
Mar. 31 2024 0.46 0.53 Beat